SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-416645"
 

Search: onr:"swepub:oai:DiVA.org:uu-416645" > Changes in Circulat...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without Type 2 Diabetes

Katsogiannos, Petros, 1979- (author)
Uppsala universitet,Klinisk diabetologi och metabolism
Kamble, Prasad G. (author)
Uppsala universitet,Klinisk diabetologi och metabolism
Pereira, Maria J., 1981- (author)
Uppsala universitet,Klinisk diabetologi och metabolism
show more...
Sundbom, Magnus (author)
Uppsala universitet,Gastrointestinalkirurgi
Carlsson, Per-Ola (author)
Uppsala universitet,Institutionen för medicinsk cellbiologi,Klinisk diabetologi och metabolism
Eriksson, Jan W. (author)
Uppsala universitet,Klinisk diabetologi och metabolism
Espes, Daniel, 1985- (author)
Uppsala universitet,Institutionen för medicinsk cellbiologi,Klinisk diabetologi och metabolism
show less...
 (creator_code:org_t)
2021-02-23
2021
English.
In: Obesity. - : Wiley. - 1930-7381 .- 1930-739X. ; 29:3, s. 535-542
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • ObjectiveThis study aimed to compare cytokine and adipokine levels in patients with obesity with and without type 2 diabetes (T2D) at baseline and 6 months after Roux‐en‐Y gastric bypass (RYGB) with healthy controls.MethodsA total of 34 patients (21 with T2D) with BMI of 30 to 45 kg/m2 were compared with 25 healthy controls without obesity. Cytokines, adipokines, and peptides of relevance for inflammation and metabolism were analyzed in plasma.ResultsSignificant decreases in weight and glycated hemoglobin A1c were observed. At baseline, interleukin‐6 (IL‐6), IFN‐β, IL‐18, leptin, and hepatocyte growth factor were higher in all patients with obesity compared with healthy controls. In patients without T2D, TNF‐α, IL‐1α, IL‐2, IL‐15, and visfatin were also increased, whereas bone morphogenic protein‐4 was decreased. Following RYGB, IL‐6 and hepatocyte growth factor were still increased in both groups compared with controls. In T2D patients, IFN‐β, IL‐27, IL‐1α, IL‐2, regenerating islet‐derived protein 3A, visfatin, and osteopontin were found to be increased. In patients without T2D, TNF‐α, IL‐1α, IL‐2, IL‐15, leptin, and visfatin remained increased.ConclusionsThe altered cytokine profile of patients with obesity persisted after RYGB despite large weight loss and improved metabolic status, thus reflecting an inherent inflammatory state.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Obesity (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view